Acytronix

Description

Acytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids through immunoaffinity capture for liquid biopsy and marker-specific EV subpopulation analysis.

Acytronix is located in the Zurich ecosystem.

Related

• TTandem TherapeuticsTandem Therapeutics develops Matrix Targeting Peptides that bind disease-associated extracellular matrix alterations, applying…
• Hedera DxHedera Dx enables hospital laboratories to perform in-house NGS genomic profiling, offering FFPE, ctDNA (liquid biopsy) and RNA-only…
• CyclomicsCyclomics develops molecular diagnostics and DNA sequencing products including the CySeq consensus sequencing and liquid biopsy platform…
• Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…
• GlycanosticsGlycanostics develops non-invasive liquid biopsy cancer diagnostics, building antibody-coated magnetic particle tests that detect glycan…
• OrixhaOrixha develops a proprietary Total Liquid Ventilation clinical platform, LuncoLive, that circulates a breathable liquid to ventilate lungs…
• Owlstone MedicalOwlstone Medical develops Breath Biopsy products and services that analyse volatile organic compounds (VOCs) from breath and other samples…
• Oxford Nanopore TechnologiesOxford Nanopore Technologies builds nanopore-based sequencing devices and workflows for research and education customers, providing…
• CovalXCovalX characterizes therapeutic proteins and biologics using mass spectrometry services, including epitope mapping, HDX-MS, XL-MS, LC-MS,…